Continuous Subcutaneous Insulin Infusion strAtegy Versus Multiple Daily Insulin Injections strAtegy

NCT01574508 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Transient Continuous Subcutaneous Insulin Infusion
DRUG: Transient Multiple Daily Insulin Injections

Sponsor

Shanghai Jiao Tong University School of Medicine